596
A. Y. RULEV AND J. MADDALUNO
97 (100). Anal. Calcd for C9H14N2O: C 65.03; H 8.49; N
16.85. Found: C 64.21; H 8.37; N 16.69%.
M ), 272 (70), 230 (65), 205 (80), 91 (100). Anal. Calcd
for C18H25NO3: C 71.26; H 8.31; N 4.62. Found: C 71.46;
H 8.49; N 4.77%.
3-[4-(tert-Butyl)cyclohex-1-en-1-yl]-1,4-dimethyl-
tetrahydropyrazin-2(1H)-one (5) (1:1 mixture of the
two diastereomers). H NMR (CDCl3), ꢀ ppm: 0.73,
4-Methyl-3-cyclopentylidenemorpholin-2-one (9a).
1H NMR (CDCl3), ꢀ ppm: 1.55–1.75. (m, 4H); 2.30–
2.40 (m, 2H); 2.55 (s, 3H); 2.55–2.75 (m, 2H); 3.00–3.10
(m, 2H); 4.20–4.25 (m, 2H). 13C NMR (CDCl3), ꢀ ppm:
26.28, 26.78, 33.23, 33.99, 42.35, 51.57, 64.75, 129.33,
1
0.74 (2 s, 9H); 0.90–1.30 (m, 2H); 1.60–2.05 (m, 5H);
2.08, 2.10 (2 s, 3H); 2.30–2.45 (m, 1H); 2.75–2.83 (m,
1H); 2.83, 2.84 (2 s, 3H); 2.90–3.00 (m, 2H); 3.45 (td,
J = 11.6, 4.5 Hz, 1H); 5.55–5.65 (m, 1H). 13C NMR
(CDCl3), ꢀ ppm: 24.32, 24.41, 25.70, 27.06, 27.23, 27.28,
27.54, 27.58, 32.50, 32.59, 34.83, 43.85, 44.01, 44.24,
44.42, 48.60, 48.66, 51.44, 51.54, 75.66, 76.28, 129.17,
149.24, 165.05. IR (KBr, cmÀ1): 1615 (C
=
C), 1729
(C=
O). MS (m/z): 181 (45, M ), 108 (100), 94 (60), 42
(70). Anal. Calcd for C10H15NO2: C 66.27; H 8.34; N
7.73. Found: C 66.19; H 8.29; N 7.56%.
129.28, 134.81, 135.14, 168.40, 168.64. IR (KBr, cmÀ1):
1654 (br s, C
=C, C
=
O). MS (m/z): 264 (17, M ), 128
4-Benzyl-3-cyclopentylidenemorpholin-2-one (9b).
1H NMR (CDCl3), ꢀ ppm: 1.60–1.80 (m, 4H); 2.42 (br
t, J = 6.5 Hz, 2H); 2.60 (br t, J = 6.5 Hz, 2H); 2.83 (br t,
J = 4.8 Hz, 2H); 3.96 (s, 2H); 4.12 (br t, J = 4.8 Hz, 2H);
7.20–7.40 (m, 5H). 13C NMR (CDCl3), ꢀ ppm: 26.29,
26.89, 33.42, 33.77, 47.78, 58.97, 64.65, 127.87, 128.50,
(65), 99 (100), 57 (93). Anal. Calcd for C16H28N2O: C
72.68; H 10.67; N 10.59. Found: C 72.77; H 10.92; N
10.50%.
Ethyl 2-cyclopent-1-en-1-yl-2-[(hydroxyethyl)(ben-
1
zyl)amino]acetate (7). H NMR (CDCl3), ꢀ ppm: 1.27
129.00, 138.27, 129.05, 150.91, 165.26. IR (KBr, cmÀ1):
(t, J = 7.3 Hz, 3H); 1.86 (quint, J = 7.3 Hz, 2H); 2.10–
3.05 (m, 6H); 3.40–3.60 (m, 2H); 3.67 (d, A part of an AB
system, J = 14.2 Hz, 1H); 3.89 (d, B part of an AB
system, J = 14.2 Hz, 1H); 4.05 (s, 1H); 4.19 (q,
J = 7.3 Hz, 2H); 5.61 (s, 1H); 7.20–7.35 (m, 5H). 13C
NMR (CDCl3), ꢀ ppm: 14.76, 23.75, 32.89, 34.73, 52.85,
55.74, 59.51, 60.88, 64.42, 127.63, 129.02, 131.23,
139.79, 128.91, 139.71, 172.65. IR (KBr, cmÀ1): 1636
1616 (C
=
C), 1732 (C
=
O). MS (m/z): 257 (36, M ), 166
(50), 91 (100). Anal. Calcd for C16H19NO2: C 74.68; H
7.44; N 5.44. Found: C 74.52; H 7.51; N 5.22%.
3-[4-(tert-Butyl)cyclohex-1-en-1-yl]-4-methylmor-
pholin-2-one (10a) (1:1 mixture of the two diaster-
eomers). 1H NMR (CDCl3), ꢀ ppm: 0.79, 0.80 (2 s, 9H);
1.00–1.30. (m, 2H); 1.80–2.20 (m, 5H); 2.15, 2.18 (2 s,
3H); 2.50–2.65 (m, 1H); 2.80–2.85 (m, 1H); 3.20, 3.21 (2
s, 1H); 4.33 (ddd, J = 10.7, 3.2, 1.8 Hz, 1H); 4.53 (td,
J = 11.4, 3.2 Hz, 1H); 5.75–5.85 (m, 1H). 13C NMR
(CDCl3), ꢀ ppm: 24.28, 24.38, 25.63, 27.31, 27.35, 27.37,
27.56, 27.60, 32.58, 32.63, 43.48, 43.66, 44.21, 44.31,
51.50, 51.42, 68.62, 75.18, 75.85, 130.43, 130.46,
(C=C), 1733 (C=O), 3448 (OH). MS (m/z): 303 (4,
M ), 272 (60), 230 (98), 120 (55), 91 (100). Anal. Calcd
for C18H25NO3: C 71.26; H 8.31; N 4.62. Found: C 71.43;
H 8.38; N 4.28%.
Ethyl
2-cyclopentylidene-2-[(2-hydroxyethyl)
(methyl)amino]acetate (8a). 1H NMR (CDCl3),
ꢀ ppm: 1.25 (t, J = 7.1 Hz, 3H); 1.55–1.70. (m, 4H);
2.44 (t, J = 6.2 Hz, 2H); 2.50 (s, 3H); 2.60 (t, J = 6.2 Hz,
2H); 2.89 (t, J = 5.2 Hz, 2H); 2.92 (br s, 1H); 3.45–3.55
(m, 2H); 4.15 (q, J = 7.1 Hz, 2H). 13C NMR (CDCl3),
ꢀ ppm: 14.80, 25.89, 27.37, 33.19, 33.56, 40.01, 57.54,
59.51, 60.39, 132.85, 158.74, 167.09. IR (KBr, cmÀ1):
133.61, 133.86, 169.29, 169.56. IR (KBr, cmÀ1): 1682
(C=
C), 1723 (C
=
O). MS (m/z): 251 (2, M ), 226 (8),
207 (64), 178 (50), 122 (100), 94 (70). Anal. Calcd for
C15H25NO2: C 71.67; H 10.02; N 5.57. Found: C 71.58;
H 10.04; N 5.44%.
1634 (C
=
C), 1704 (C
=
O), 3451 (OH). MS (m/z): 227
3-[4-(tert-Butyl)cyclohex-1-en-1-yl]-4-benzylmor-
pholin-2-one (10b) (1:1 mixture of the two
diastereomers)
(13, M ), 196 (90), 81 (80), 42 (100). Anal. Calcd for
C12H21NO3: C 63.41; H 9.31; N 6.16. Found: C 63.45; H
9.28; N 6.44%.
1H NMR (CDCl3), ꢀ ppm: 0.78, 0.79 (2 s, 9H); 1.00–1.30
(m, 2H); 1.70–2.20 (m, 5H); 2.38 (qd, J = 12.0, 3.4 Hz,
1H); 2.75–2.85 (m, 1H); 2.97 (d, A part of an AB system,
J = 13.6 Hz, 1H); 3.53, 3.54 (2 s, 1H); 3.92 (dd, B part of
an AB system, J = 18.7, 13.6 Hz, 1H); 4.15–4.25 (m, 1H);
4.31 (td, J = 11.0, 3.0 Hz, 1H); 5.78–5.87 (m, 1H); 7.15–
7.35 (m, 5H). 13C NMR (CDCl3), ꢀ ppm: 24.62, 26.20,
27.67, 28.13, 27.84, 27.87, 32.86, 32.92, 44.50, 44.56,
47.63, 58.88, 59.16, 69.26, 73.90, 74.50, 128.02, 128.04,
129.35, 129.44, 131.40, 131.44, 138.41, 138.48, 129.17,
133.98, 134.27, 169.71, 169.97. IR (KBr, cmÀ1): 1678
Ethyl 2-cyclopentylidene-2-[(2-hydroxyethyl)(ben-
zyl)amino]acetate (8b). 1H NMR (CDCl3), ꢀ ppm:
1.26 (t, J = 7.2 Hz, 3H); 1.40–1.65. (m, 4H); 2.32 (t,
J = 7.0 Hz, 2H); 2.56 (t, J = 7.0 Hz, 2H); 2.91 (br s, 1H);
2.96 (t, J = 5.0 Hz, 2H); 3.44 (br s, 2H); 3.92 (s, 2H); 4.16
(q, J = 7.2 Hz, 2H); 7.15–7.30 (m, 5H). 13C NMR
(CDCl3), ꢀ ppm: 14.82, 25.93, 27.24, 33.25, 34.15,
55.41, 58.15, 60.36, 60.63, 127.51, 128.66, 129.41,
139.81, 131.14, 159.95, 167.54. IR (KBr, cmÀ1): 1631
(C=C), 1701 (C=O), 3446 (OH). MS (m/z): 303 (4,
Copyright 2002 John Wiley & Sons, Ltd.
J. Phys. Org. Chem. 2002; 15: 590–598